Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre studyHenri Montaudié, Frédéric Peyrade, Julie De Quatrebarbes et al.|Oncotarget|2020Cited by 56
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studyS. Monestier, Stéphane Dalle, Laurent Mortier et al.|International Journal of Cancer|2021Cited by 9
Cetuximab in patients with unresectable cutaneous squamous cell carcinoma is safe and effective: A real-life analysisFrédéric Peyrade, Henri Montaudié, Maria Kogay et al.|Annals of Oncology|2018Cited by 6
Epidemiological study of unknown primary melanoma patients from the French national melanoma database RIC-Mel.Émilie Varey, Stéphane Dalle, Jean‐Michel Nguyen et al.|Journal of Clinical Oncology|2018Cited by 2
Données d’efficacité et de tolérance en vie réelle du cétuximab dans le carcinome épidermoïde cutané avancé : étude nationale rétrospective et multicentriqueHenri Montaudié, Frédéric Peyrade, Maria Kogay et al.|Annales de Dermatologie et de Vénéréologie|2018Cited by 1